New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Global - North America
Archived
•
September 30, 2026
•
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Source: NYT Home Page | https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



